48 results on '"Schiffmann, Jonas"'
Search Results
2. Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical Prostatectomy
3. External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer
4. Local Therapy Improves Survival in Metastatic Prostate Cancer
5. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression
6. Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy
7. Limitations of Elastography Based Prostate Biopsy
8. Transrectal Ultrasound (US), Contrast-enhanced US, Real-time Elastography, HistoScanning, Magnetic Resonance Imaging (MRI), and MRI-US Fusion Biopsy in the Diagnosis of Prostate Cancer
9. Cardiovascular Mortality in Patients With Metastatic Prostate Cancer Exposed to Androgen Deprivation Therapy: A Population-Based Study
10. Shear Wave Elastography for Localization of Prostate Cancer Lesions and Assessment of Elasticity Thresholds: Implications for Targeted Biopsies and Active Surveillance Protocols
11. Histoscanning Has Low Sensitivity and Specificity for Seminal Vesicle Invasion
12. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification
13. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer
14. Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: Results from the North-American case-control study Prostate Cancer & Environment Study
15. Heterogeneity in D׳Amico classification–based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility
16. MP97-09 VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS UNDERGOING OPEN AND MINIMALLY INVASIVE RADICAL PROSTATECTOMY: POPULATION-BASED TIME TREND ANALYSIS
17. PD51-12 ONCOLOGICAL AND FUNCTIONAL OUTCOMES AFTER RP FOR HIGH OR VERY HIGH-RISK PROSTATE CANCER – EUROPEAN VALIDATION OF THE CURRENT NCCN GUIDELINE
18. MP47-04 OBESITY WAS ASSOCIATED WITH IMPROVED METASTASES-FREE SURVIVAL AFTER SURGERY IN 13,667 PROSTATE CANCER PATIENTS
19. MP20-03 POPULATION-BASED VALIDATION OF THE 2014 ISUP GLEASON GRADING GROUPING IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY, BRACHYTHERAPY, EXTERNAL BEAM RADIATION OR NO LOCAL TREATMENT
20. PD31-13 PERI-OPERATIVE MORTALITY AND LONG-TERM SURVIVAL AFTER PARTIAL VERSUS RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER
21. MP78-17 IDENTIFYING THE MOST INFORMATIVE PREDICTION-TOOL FOR CANCER SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY: COMPARATIVE ANALYSIS OF THREE COMMONLY USED PREOPERATIVE PREDICTION MODELS
22. MP78-09 5-YEARS BIOCHEMICAL RECURRENCE AND OVERALL SURVIVAL RATES AFTER RADICAL PROSTATECTOMY OR HIGH DOSE RADIATION BRACHYTHERAPY WITH ADDITIONAL EXTERNAL BEAM IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER
23. PD49-03 MORTALITY, MORBIDITY AND HEALTHCARE EXPENDITURES AFTER LOCAL TUMOR ABLATION OR PARTIAL NEPHRECTOMY FOR T1A KIDNEY CANCER
24. MP59-18 COMPREHENSIVE ASSESSMENT OF CONTEMPORARY SHORT-, INTERMEDIATE-, AND LONG-TERM ENDPOINTS AFTER EITHER PARTIAL NEPHRECTOMY OR MINIMALLY-INVASIVE RADICAL NEPHRECTOMY
25. MP83-18 LYMPHATIC VESSEL INVASION PREDICTS BIOCHEMICAL RECURRENCE IN ORGAN CONFINED PROSTATE CANCER. RESULTS OF 2316 EUROPEAN PATIENTS WITHOUT LYMPHNODE DISSECTION
26. MP83-07 SALVAGE RADICAL PROSTATECTOMY FOR RECURRENT PROSTATE CANCER: VERIFICATION OF EAU GUIDELINE CRITERIA
27. PD30-06 MORTALITY RISK FACTORS IN EUROPEAN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY. COMPETING RISK ANALYSIS WITH 15-YEARS FOLLOW UP
28. MP78-07 THE IMPORTANCE OF OTHER CAUSE MORTALITY AND CARDIOVASCULAR MORBIDITY IN PATIENTS WITH METASTATIC PROSTATE CANCER EXPOSED TO CONVENTIONAL ANDROGEN DEPRIVATION THERAPY
29. MP70-09 PATTERNS OF USE OF BONE TARGETED THERAPY IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS: A POPULATION BASED STUDY
30. MP67-13 DOES HISTOSCANNING (™) PREDICT POSITIVE RESULTS IN PROSTATE BIOPSY? A RETROSPECTIVE ANALYSIS OF 1,188 SEXTANTS OF THE PROSTATE
31. MP67-09 RISK ASSESSMENT TO PREDICT A POSITIVE BIOPSY USING SHEARWAVE ELASTOGRAPHY.
32. MP61-06 NEOADJUVANT CHEMOTHERAPY IS NOT ASSOCIATED WITH WORSE SHORT-TERM OUTCOMES IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY: A POPULATION-BASED STUDY
33. MP58-09 INCIDENCE OF INSIGNIFICANT PROSTATE CANCER: A REPORT OF 955 CONSECUTIVE PATIENTS UNDERGOING RADICAL PROSTATECTOMY IN A HIGH VOLUME PROSTATE CANCER CENTER
34. MP58-06 BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: IS EVERY PATIENT WITH A PSA OF 0.1NG/ML REALLY RECURRING?
35. MP60-17 SUBOPTIMAL USE OF NEOADJUVANT OR ADJUVANT CHEMOTHERAPY IN RADICAL CYSTECTOMY PATIENTS: A POPULATION-BASED STUDY
36. MP60-11 90-DAY MORTALITY REPRESENTS A MORE REALISTIC ENDPOINT THAN 30-DAY MORTALITY AFTER RADICAL CYSTECTOMY
37. MP53-15 SHEARWAVE ELASTOGRAPHY FOR LOCALIZATION OF PROSTATE CANCER LESIONS AND ASSESSMENT OF ELASTICITY THRESHOLDS: IMPLICATIONS FOR TARGETED BIOPSIES AND ACTIVE SURVEILLANCE PROTOCOLS
38. MP46-16 REVISITED: USE OF PROERECTILE MEDICATION (PDE5-I) IS AN INDEPENDENT RISK FACTOR FOR PSA RECURRENCE FOLLOWING RADICAL PROSTATECTOMY
39. MP46-13 DIABETES AND THERAPY OF DIABETES HAD NO IMPACT ON BCR FOLLOWING RADICAL PROSTATECTOMY (RP). RESULTS FROM NEARLY 4200 CONTEMPORARY PATIENTS
40. PD15-05 PREDICTION OF LOCALLY ADVANCED PROSTATE CANCER AND TUMOR VOLUME WITH SHEARWAVE ELASTOGRAPHY PRIOR TO RADICAL PROSTATECTOMY: IMPACT ON ACTIVE SURVEILLANCE AND SELECTION FOR PROSTATE BIOPSY
41. PD14-08 AMOUNT OF DISSECTED LYMPH NODES DURING RADICAL PROSTATECTOMY DOES NOT DEPEND ON SURGICAL APPROACH IN A SINGLE HIGH-VOLUME CENTER
42. PD14-12 CLAVIEN IIIB COMPLICATIONS AFTER OPEN RETROPUBIC AND ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY IN A SINGLE HIGH-VOLUME CENTER
43. MP37-07 COMPARATIVE EFFECTIVENESS OF ROBOTIC-ASSISTED VERSUS OPEN RADICAL PROSTATECTOMY CANCER CONTROL OUTCOMES
44. MP50-09 COMPARATIVE EFFECTIVENESS OF RADICAL CYSTECTOMY VERSUS BLADDER-SPARING TREATMENT FOR MUSCLE-INVASIVE UROTHELIAL CARCINOMA: A POPULATION-BASED REPORT.
45. PD12-11 SURVIVAL BENEFIT OF RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY ADVANCED PROSTATE CANCER: ESTIMATIONS OF THE NUMBER NEEDED TO TREAT BASED ON COMPETING-RISKS ANALYSIS
46. PD12-12 ADJUVANT RADIOTHERAPY IMPROVES CANCER-SPECIFIC SURVIVAL ONLY IN PATIENTS WITH HIGHLY AGGRESSIVE PROSTATE CANCER. VALIDATION OF RECENTLY RELEASED CRITERIA
47. PD12-04 THE EFFECT OF AGE AT DIAGNOSIS ON PROSTATE CANCER MORTALITY: A GRADE-FOR-GRADE AND STAGE-FOR-STAGE ANALYSIS
48. MP10-19 DEVELOPMENT AND EXTERNAL VALIDATION OF A PROGNOSTIC TOOL FOR PREDICTION OF CANCER-SPECIFIC MORTALITY AFTER COMPLETE LOCO-REGIONAL PATHOLOGICAL STAGING FOR SQUAMOUS CELL CARCINOMA OF THE PENIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.